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Introduction 
Atrial flutter (AF) is the reentrance of 
signals in the atria resulting in beating up to 
five times faster than normal (i.e., 240-400 
bpm).
1
 Common symptoms experienced 
during an episode of atrial flutter includes 
palpitations, dizziness, chest tightness, 
shortness of breath, and fatigue. To manage 
atrial flutter, four major concerns must be 
addressed: (1) reversion to normal sinus 
rhythm (NSR), (2) maintenance of NSR, (3) 
control of the ventricular rate, and (4) 
prevention of systemic embolization. 
Antiarrhythmic (AA) medications can be 
used to either ‘‘pharmacologically convert” 
a person to NSR or to maintain it following 
an external electrical cardioversion.
2
 
Several medications are available for the 
treatment of atrial flutter including 
diltiazem, digoxin, and amiodarone. 
Adenosine, which is used for the treatment 
of paroxysmal supraventricular tachycardia 
(PSVT), is not indicated for the treatment of 
AF primarily due to its very short half-life.  
We present a case of atrial flutter with 
rapid ventricular response, which was 
converted to NSR by administering a single 
dose of adenosine in a patient who 
underwent a surgical resection of cardiac 
leiomyosarcoma. 
 
 
 
Case Report 
A 51-year-old Caucasian male presented 
with abdominal pain and palpitations. On 
electrocardiogram, he had atrial fibrillation 
with a heart rate of 90 bpm. There was 
evidence of a large right atrial mass on 2-D 
echocardiogram. He was started on 
diltiazem infusion and rapidly converted to 
NSR. He also had tamponade and underwent 
pericardiocentesis successfully.  
The patient was discharged home on 
diltiazem 120 mg daily then later readmitted 
to the hospital for surgical removal of the 
cardiac mass. The pathology was positive 
for leiomyosarcoma. Postoperatively (Day 
0), he developed AF and was treated with 
amiodarone. On post-operative day 1, he 
developed another episode of rapid AF 
which was treated with digoxin. The next 
day, he had a third episode of AF with a rate 
of 114 bpm (Figure 1). The electro-
cardiogram was misinterpreted as supra-
ventricular tachycardia rather than atrial 
flutter with atrioventricular (AV) block.  
Adenosine 12 mg was administered 
intravenously resulting in atrioventricular 
block (Figure 2) followed by rapid 
conversion to NSR. An electrocardiogram 
taken about 15 minutes after adenosine 
infusion showed a NSR (Figure 3). 
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Figure 1. Atrial flutter with a rapid ventricular response. 
 
Figure 2. Atrial flutter/fibrillation shown with the administration of adenosine (black arrow). 
 
Figure 3. Normal sinus rhythm shown three hours after administration of adenosine. 
Discussion
Adenosine is a potent chemical which 
has cardiac electrophysiologic effects 
including a negative chronotropic action on 
the sinus node and a predominant negative 
dromotropic action on the AV node.
3
 The 
negative dromotropic action has led mainly 
to the use of adenosine as a potent 
antiarrhythmic agent for paroxysmal 
supraventricular tachycardia (PSVT) 
mediated by a reentrant mechanism 
involving the AV node. The effects of 
adenosine are dose-dependent and of very 
short duration since the half-life is less than 
10 seconds.
4
 This effect likely is related to 
the activation of the autonomic nervous 
system, mainly sympathetic, that occurs 
after administration of adenosine. Due to the 
short half-life, the sympathetic effects of 
adenosine are short-lived. The onset of 1:1 
conduction most likely further increases 
sympathetic stimulation, thereby preventing 
return to 2:1 atrioventricular nodal 
conduction.
5
 
There is limited reported experience of 
the use of adenosine in patients with atrial 
arrhythmias and 2:1 AV block. In one study, 
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adenosine administered to patients with 
atrial flutter and 2:1 block was not 
associated with acceleration of ventricular 
rate.
5
 No adverse effects were noted when 
adenosine was administered to 14 patients 
with intra-atrial reentrant tachycardia, 
though the number of patients who received 
the drug in the presence of 2:1 
atrioventricular nodal block was not 
reported.
6
 These studies together with the 
fact that rhythm acceleration was not seen 
when adenosine was given to eight patients 
with atrial flutter and 2:1 conduction block 
through an accessory atrioventricular 
connection (where there are no counter-
acting effects of adenosine-induced 
conduction block) suggested that the effect 
of adenosine-induced sympathetic stimu-
lation is likely to be small.
6,7
 In this case, the 
fact that it was sufficient to allow 1:1 
atrioventricular nodal conduction likely was 
related to a combination of a relatively slow 
flutter rate (because of previous anti-
arrhythmic therapy), an unusually short AV 
nodal refractory period in the baseline state, 
and the use of a relatively high dose of 
adenosine.
8 
 
Conclusion 
Our case suggested a possible role of 
adenosine in the rhythm control. The current 
medications (i.e., amiodarone, procain-
amide, and sotalol) used for this purpose 
require multiple administrations and have a 
wide range of toxicities making the 
possibility of using a single intravenous dose 
of adenosine an excellent alternative. 
Further studies are required before 
recommending adenosine, except as a last 
resort when more standard treatment has 
failed. 
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